Synopsis
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
24
PharmaCompass offers a list of Pentoxiverine citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pentoxiverine citrate manufacturer or Pentoxiverine citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pentoxiverine citrate manufacturer or Pentoxiverine citrate supplier.
A Carbetapentane Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbetapentane Citrate, including repackagers and relabelers. The FDA regulates Carbetapentane Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbetapentane Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carbetapentane Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Carbetapentane Citrate supplier is an individual or a company that provides Carbetapentane Citrate active pharmaceutical ingredient (API) or Carbetapentane Citrate finished formulations upon request. The Carbetapentane Citrate suppliers may include Carbetapentane Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Carbetapentane Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Carbetapentane Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Carbetapentane Citrate active pharmaceutical ingredient (API) in detail. Different forms of Carbetapentane Citrate DMFs exist exist since differing nations have different regulations, such as Carbetapentane Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carbetapentane Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Carbetapentane Citrate USDMF includes data on Carbetapentane Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carbetapentane Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carbetapentane Citrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Carbetapentane Citrate Drug Master File in Japan (Carbetapentane Citrate JDMF) empowers Carbetapentane Citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Carbetapentane Citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Carbetapentane Citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Carbetapentane Citrate suppliers with JDMF on PharmaCompass.
A Carbetapentane Citrate CEP of the European Pharmacopoeia monograph is often referred to as a Carbetapentane Citrate Certificate of Suitability (COS). The purpose of a Carbetapentane Citrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbetapentane Citrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbetapentane Citrate to their clients by showing that a Carbetapentane Citrate CEP has been issued for it. The manufacturer submits a Carbetapentane Citrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbetapentane Citrate CEP holder for the record. Additionally, the data presented in the Carbetapentane Citrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbetapentane Citrate DMF.
A Carbetapentane Citrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbetapentane Citrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbetapentane Citrate suppliers with CEP (COS) on PharmaCompass.
Carbetapentane Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carbetapentane Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Carbetapentane Citrate GMP manufacturer or Carbetapentane Citrate GMP API supplier for your needs.
A Carbetapentane Citrate CoA (Certificate of Analysis) is a formal document that attests to Carbetapentane Citrate's compliance with Carbetapentane Citrate specifications and serves as a tool for batch-level quality control.
Carbetapentane Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Carbetapentane Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carbetapentane Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Carbetapentane Citrate EP), Carbetapentane Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carbetapentane Citrate USP).
